Ionis announces presentation of positive Phase 2b data for chronic hepatitis B treatment at the EASL International Liver Congress™ ...Middle East

PR Newswire - News
Ionis announces presentation of positive Phase 2b data for chronic hepatitis B treatment at the EASL International Liver Congress™
- Interim analysis of B-Clear clinical study of bepirovirsen demonstrated end-of-treatment virologic response (VR) in patients with chronic hepatitis B - Phase 3 clinical study evaluating bepirovirsen as a monotherapy is anticipated to start in the first half of 2023 - GSK to explore...

Hence then, the article about ionis announces presentation of positive phase 2b data for chronic hepatitis b treatment at the easl international liver congress was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Ionis announces presentation of positive Phase 2b data for chronic hepatitis B treatment at the EASL International Liver Congress™ )

Apple Storegoogle play

Last updated :

Also on site :